Strength
2.5 mg/1
Manufacturer
AvPAKNDC
50268047615
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LETROZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA200161On Market Since
10/2/2019
Pharmacological Classes
Price Statistics
The NADAC for LETROZOLE 2.5 MG TABLET has been published 340 times since Dec 25, 2019, and over the history we have for it it has risen 15.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1535 per EA |
|---|---|
| All-time high | $0.1535 (Jun 24, 2026) |
| All-time low | $0.1009 (Jun 21, 2023) |
| 52-week high | $0.1535 |
| 52-week low | $0.1292 |
| Median price | $0.1406 |
| Average price | $0.1352 |
| Largest weekly change | +32.3% (Nov 22, 2023) |
| Weeks tracked | 340 |
| Tracking since | Dec 25, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LETROZOLE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LETROZOLE 2.5 MG TABLET, manufactured by AvPAK, is $0.1535 per EA (NDC 50268047615), effective Jun 24, 2026.
How has the price of LETROZOLE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LETROZOLE 2.5 MG TABLET has risen 15.8%. It has been tracked across 340 weekly CMS publications since Dec 25, 2019.
What are the highest and lowest recorded NADAC prices for LETROZOLE 2.5 MG TABLET?
Since Dec 25, 2019, the NADAC for LETROZOLE 2.5 MG TABLET has ranged from a low of $0.1009 (Jun 21, 2023) to a high of $0.1535 (Jun 24, 2026), with a median of $0.1406 per EA.
Are there cheaper alternatives to LETROZOLE 2.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LETROZOLE 2.5 MG TABLET, but none are currently priced below it.
Who manufactures LETROZOLE 2.5 MG TABLET?
LETROZOLE 2.5 MG TABLET (NDC 50268047615) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification